Salpingectomy vs Tubal Sterilisation in Low Risk for Ovarian Cancer Women and Its Effect on Ovarian Reserve

Not Applicable

• Conditions: Ovarian Cancer

• Registration Number: NCT01888159
• Lead Sponsor: Karlstad Central Hospital

Brief Summary

Randomised study to investigate if salpingectomies done to women wishing tubal sterilisation has an effect on ovarian reserve.

Detailed Description

Not available

Study Timeline

• Status Verified: 2013-06
• Study First Submitted: 2013-06-20
• Study First Submitted QC: 2013-06-25
• Last Update Submitted: 2013-06-25
• Study First Posted: 2013-06-27
• Last Update Posted: 2013-06-27
• Study Start: 2013-09
• Primary Completion: 2014-09

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

• Women seeking for tubal sterilisation

Exclusion Criteria

• women older than 45
• family history of ovarian cancer
• presence of menopausal symptoms
• irregular cycles
• Hormone Replacement Therapy or hormone contraceptions the last 3 months
• history of previous ovarian or uterine surgeries
• imaging suggesting an ovarian cyst or other adnexal pathology during investigation
• previous salpingectomy

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Anti-Mullerian hormone (AMH)and Follicle Stimulation Hormone (FSH)	3 months

Secondary Outcome Measures

Name	Time	Method
Anti-Mullerian hormone (AMH)	1 year
Operative time	Postoperatively
Complications	3 months

Trial Locations

Locations (1)

Department of Obstetrics and Gynecology; 🇸🇪 Karlstad, Värmaland, Sweden